These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


56 related items for PubMed ID: 21474972

  • 1. Localization of the invadopodia-related proteins actinin-1 and cortactin to matrix-contact-side cytoplasm of cancer cells in surgically resected lung adenocarcinomas.
    Hirooka S, Akashi T, Ando N, Suzuki Y, Ishida N, Kurata M, Takizawa T, Kayamori K, Sakamoto K, Fujiwara N, Kojima M, Eishi Y.
    Pathobiology; 2011; 78(1):10-23. PubMed ID: 21474972
    [Abstract] [Full Text] [Related]

  • 2. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
    Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC.
    Exp Cell Res; 2006 May 01; 312(8):1240-53. PubMed ID: 16442522
    [Abstract] [Full Text] [Related]

  • 3. Diaphanous-related formins are required for invadopodia formation and invasion of breast tumor cells.
    Lizárraga F, Poincloux R, Romao M, Montagnac G, Le Dez G, Bonne I, Rigaill G, Raposo G, Chavrier P.
    Cancer Res; 2009 Apr 01; 69(7):2792-800. PubMed ID: 19276357
    [Abstract] [Full Text] [Related]

  • 4. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES, Whigham AS, Yarbrough WG, Weaver AM.
    Cancer Res; 2007 May 01; 67(9):4227-35. PubMed ID: 17483334
    [Abstract] [Full Text] [Related]

  • 5. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
    Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC.
    Oncogene; 1999 Aug 05; 18(31):4440-9. PubMed ID: 10442635
    [Abstract] [Full Text] [Related]

  • 6. HDAC6 is required for invadopodia activity and invasion by breast tumor cells.
    Rey M, Irondelle M, Waharte F, Lizarraga F, Chavrier P.
    Eur J Cell Biol; 2011 Aug 05; 90(2-3):128-35. PubMed ID: 20970878
    [Abstract] [Full Text] [Related]

  • 7. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA, Jia L, Eves R, Mak AS.
    Eur J Cell Biol; 2007 Apr 05; 86(4):189-206. PubMed ID: 17343955
    [Abstract] [Full Text] [Related]

  • 8. Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.
    Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R.
    J Cell Sci; 2008 Feb 01; 121(Pt 3):369-78. PubMed ID: 18198194
    [Abstract] [Full Text] [Related]

  • 9. Increased C-CRK proto-oncogene expression is associated with an aggressive phenotype in lung adenocarcinomas.
    Miller CT, Chen G, Gharib TG, Wang H, Thomas DG, Misek DE, Giordano TJ, Yee J, Orringer MB, Hanash SM, Beer DG.
    Oncogene; 2003 Sep 11; 22(39):7950-7. PubMed ID: 12970743
    [Abstract] [Full Text] [Related]

  • 10. Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung.
    Kamimura A, Kamachi M, Nishihira J, Ogura S, Isobe H, Dosaka-Akita H, Ogata A, Shindoh M, Ohbuchi T, Kawakami Y.
    Cancer; 2000 Jul 15; 89(2):334-41. PubMed ID: 10918163
    [Abstract] [Full Text] [Related]

  • 11. CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.
    Miyazawa Y, Uekita T, Hiraoka N, Fujii S, Kosuge T, Kanai Y, Nojima Y, Sakai R.
    Cancer Res; 2010 Jun 15; 70(12):5136-46. PubMed ID: 20501830
    [Abstract] [Full Text] [Related]

  • 12. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
    Irie K, Ishida H, Furukawa T, Koyanagi K, Miyamoto Y.
    Rinsho Byori; 1996 Jan 15; 44(1):32-41. PubMed ID: 8691638
    [Abstract] [Full Text] [Related]

  • 13. Extravasation during bladder cancer metastasis requires cortactin‑mediated invadopodia formation.
    Tokui N, Yoneyama MS, Hatakeyama S, Yamamoto H, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S.
    Mol Med Rep; 2014 Apr 15; 9(4):1142-6. PubMed ID: 24549769
    [Abstract] [Full Text] [Related]

  • 14. Expression of survivin correlated with vessel invasion is a marker of poor prognosis in small adenocarcinoma of the lung.
    Ikehara M, Oshita F, Kameda Y, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A.
    Oncol Rep; 2002 Apr 15; 9(4):835-8. PubMed ID: 12066218
    [Abstract] [Full Text] [Related]

  • 15. Simultaneous expression of Cathepsins B and K in pulmonary adenocarcinomas and squamous cell carcinomas predicts poor recurrence-free and overall survival.
    Cordes C, Bartling B, Simm A, Afar D, Lautenschläger C, Hansen G, Silber RE, Burdach S, Hofmann HS.
    Lung Cancer; 2009 Apr 15; 64(1):79-85. PubMed ID: 18760860
    [Abstract] [Full Text] [Related]

  • 16. Actinin-1 and actinin-4 play essential but distinct roles in invadopodia formation by carcinoma cells.
    Yamaguchi H, Ito Y, Miura N, Nagamura Y, Nakabo A, Fukami K, Honda K, Sakai R.
    Eur J Cell Biol; 2017 Oct 15; 96(7):685-694. PubMed ID: 28797528
    [Abstract] [Full Text] [Related]

  • 17. Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.
    Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K.
    Cancer Res; 2009 Nov 15; 69(22):8594-602. PubMed ID: 19887621
    [Abstract] [Full Text] [Related]

  • 18. The phosphatase Shp1 interacts with and dephosphorylates cortactin to inhibit invadopodia function.
    Varone A, Amoruso C, Monti M, Patheja M, Greco A, Auletta L, Zannetti A, Corda D.
    Cell Commun Signal; 2021 Jun 04; 19(1):64. PubMed ID: 34088320
    [Abstract] [Full Text] [Related]

  • 19. HOXB2, an adverse prognostic indicator for stage I lung adenocarcinomas, promotes invasion by transcriptional regulation of metastasis-related genes in HOP-62 non-small cell lung cancer cells.
    Inamura K, Togashi Y, Ninomiya H, Shimoji T, Noda T, Ishikawa Y.
    Anticancer Res; 2008 Jun 04; 28(4B):2121-7. PubMed ID: 18751384
    [Abstract] [Full Text] [Related]

  • 20. Clinical implication and prognostic significance of the tumor suppressor TSLC1 gene detected in adenocarcinoma of the lung.
    Uchino K, Ito A, Wakayama T, Koma Y, Okada T, Ohbayashi C, Iseki S, Kitamura Y, Tsubota N, Okita Y, Okada M.
    Cancer; 2003 Sep 01; 98(5):1002-7. PubMed ID: 12942568
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.